Shares of Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) have been assigned an average recommendation of “Hold” from the six brokerages that are currently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, two have given a hold recommendation, one has issued a buy recommendation and one has assigned a strong buy recommendation to the company.
Several equities research analysts recently commented on SAUHY shares. Citigroup reiterated a “sell” rating on shares of Straumann in a research report on Wednesday, January 14th. Morgan Stanley restated an “underweight” rating on shares of Straumann in a research report on Monday, December 15th.
Read Our Latest Report on SAUHY
Straumann Price Performance
About Straumann
Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.
In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.
Featured Articles
- Five stocks we like better than Straumann
- The $8,000 Gold Call Every Retirement Saver Needs to Read Right Now
- A personal warning from Martin Weiss (Please read)
- Elon Musk: This Could Turn $100 into $100,000
- America’s gold reserves are priced at $42. The real price is $6,000+.
- Central banks just did something they haven’t done since 1967
Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.
